PAR-24-301: NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)
NIH’s NICHD P41 funding opportunity supports mature bioinformatics resources for developmental biology and birth-defects research using animal models through multi-component infrastructure and community-oriented tools, data, and training.
PAR-24-301: NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)
At a glance
This is a recurring, multi-cycle NIH grant announcement for infrastructure and platform development rather than a short-term experimental study. The opportunity supports the continued operation, maintenance, and distribution of bioinformatics resources for researchers using animal models of embryonic development. It was reissued as PAR-24-301 and remains relevant through 2027 with rolling standard due dates, making it particularly useful for groups that already manage mature resources but need sustained multi-year support.
For readers, this matters if your team has an established database, annotation pipeline, model-organism interface, or computational services that are already being used by a broader developmental biology community and can demonstrate ongoing impact.
| Field | Detail |
|---|---|
| Funding org | National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
| Activity | P41 (Biotechnology Resource Grants), Clinical Trial Not Allowed |
| Mechanism | Multi-component research program grant |
| Amount | $500,000–$1,750,000 in direct costs per year |
| Project period | Up to 5 years |
| Eligibility | Broad U.S. eligible institutions and organizations; foreign organizations not eligible |
| Next key due date (for your planning) | 2026-09-25 |
| Expiration | 2027-09-26 |
| Official source | NIH grants guide NOFO |
What this funding covers
This opportunity is for resource-building and resource-sustaining infrastructure. It explicitly supports:
- Ongoing development and maintenance of knowledge, data, and computational resources for developmental biology research.
- Community-facing tools and services, including data storage, curation, and dissemination.
- Interoperability with other NIH bioinformatics systems (for example, data exchange strategies and API-enabled integration).
- User support and training so that external researchers can actually adopt and reuse the resource.
It is not meant for speculative tool prototyping alone. The NOFO says it does not fund novelty-focused proof-of-concept work and does not support projects that simply use an existing resource without contributing to it in a substantial, community-relevant way. If your proposal is primarily a pilot study to test feasibility, there are other mechanisms better matched to that scope.
This NOFO defines “Resource Program” outcomes in practical terms: a mature, verifiable, and used resource with demonstrable value to researchers. The applicant pool often performs best when the submitted plan links three things clearly:
- The unmet scientific need the resource addresses,
- How data/standards/infrastructure upgrades solve that need,
- How adoption, usage, and maintenance will continue past the award period.
Because this is not a clinical mechanism, projects must avoid clinical-trial activities. If any part of your proposal introduces clinical interventions or human trial-like protocols, the application will be non-compliant and likely deferred.
Key dates and cycle status for 2026/2027
The NOFO has recurring due dates. As of your target planning window, the relevant dates are:
- 2026-09-25
- 2027-01-25
- 2027-05-25
- 2027-09-25
All NIH dates above include that submissions are due at 5:00 PM local applicant time and are rounded to the next business day if they fall on a weekend or federal holiday. The page also lists due dates from earlier years, confirming a regular cycle pattern and signaling this is not a one-off one-time call. The posted/expiration metadata indicates an explicit expiration on 2027-09-26, which means this is still within the active window for late-2026 and early-2027 applicants.
What makes this one useful now:
- If you already have a running resource, you can prepare a “renewal-ready” package for the next cycle.
- If your effort is in mid-development, the NOFO still prefers mature resources already showing utility and support metrics.
- If you have been tracking community usage, publication linkage, or adoption indicators (downloads, API calls, tool citations), now is the time to package that as evidence.
A practical planning sequence for 2026 is:
- Confirm internal sponsor and PI capacity.
- Finalize component structure of your application (Overall + necessary cores/components).
- Run mock submission before the September 25 due date.
- Submit at least a few business days early (NIH explicitly encourages this due to mandatory error-correction cycles).
Eligibility and fit
The opportunity opens to a surprisingly broad set of U.S. entities:
- Higher education institutions (public/private)
- Nonprofits (including 501(c)(3) and non-501(c)(3))
- Small businesses and other for-profit organizations
- Federal and local public institutions (including city, county, state, tribal, and U.S. territorial entities where eligible)
- Selected community, school district, and regional organizations
Foreign entities and non-U.S. components are not eligible. That constraint is strict and should be reflected in team construction and budget authority.
Who this fits best
This NOFO is best for:
- Existing databases, atlases, annotation systems, or resource hubs in developmental biology.
- Projects with clear evidence of external community demand.
- Consortia or institutions already managing a portfolio of bioinformatics assets for animal models.
- Teams planning strong interoperability, curation standards, and open dissemination models.
Strong fit indicators
- Usage is already measurable, ideally with citations, integration agreements, or broad user adoption.
- You can demonstrate sustained community benefit and not just institutional value.
- Existing data assets are generated and maintained under FAIR principles (Findable, Accessible, Interoperable, Reusable).
- You have an organized plan for governance, operations, and service quality.
What may reduce competitiveness
- Proposals where the project is mostly a brand-new idea without demonstrated utility.
- Tool-building without evidence that the community is ready to use it.
- Duplicative efforts that mirror widely funded NIH or NLM resources.
- Weak quality-control and curation procedures.
Application process and required setup
The NOFO requires full compliance with NIH submission pathways through Grants.gov and eRA systems. Submission is electronic only, using either ASSIST or an institutional system-to-system flow.
Required registrations before submission
You must complete and keep active:
- SAM registration
- UEI setup (from SAM)
- eRA Commons registration
- Grants.gov compatibility profile/access
This is not optional prep. NIH explicitly states that delayed registrations are not a valid reason for late submissions, and registration can take weeks.
Form and structure expectations
Because this is a multi-component grant, you should treat the budget and narrative as a coordinated program rather than a single-component grant. The NOFO lists component types such as:
- Overall
- Administrative Core
- Curation
- Technical Development
- Computation
- Dissemination
Each component generally has strict instructions for sections like SF424 cover fields and project performance site details, and it is not unusual for successful submissions to require consistency across components with distinct role naming and concise component-level justifications.
Important application expectations from the NOFO text:
- Use the Overall component to define the unifying program strategy and demonstrate community impact.
- Keep component-specific aims and methods coherent with the overall program logic.
- Use appropriate role definitions (for example, project lead or core lead with valid eRA credentials).
- Include letters of support where relevant to a component.
- Use the required data and reporting formats and avoid adding non-required appendices.
Review criteria and what reviewers actually score
Review is multi-layered, with both broad and component-level criteria. Core review themes include:
- Significance and scientific rationale of the Resource Program.
- Maturity, utility, and community adoption of the proposed resource.
- Rigor and robustness of methods, including risk management and alternatives.
- Quality-control procedures, FAIR-aligned interoperability, and data/metadata governance.
- Qualifications of leadership and team.
- Cost realism versus scope and duration.
The NOFO also calls out resource-sharing plans and authenticity of key biological resources, plus environment and institutional readiness.
From a reviewer perspective, this means “why this resource matters” and “how you run and sustain it” carry equal weight with the technical plan. A technically polished method section without an adoption/sustainability story often underperforms.
Proposal strategy for 2026/2027 applicants
Build a reviewable program logic
Create a single-page model that connects:
- The pain point in the developmental biology community,
- The resource outputs or services that solve it,
- The mechanisms for dissemination and external reuse,
- Success benchmarks for each year.
This is especially important because reviewers check maturity and utility across multiple dimensions.
Evidence you should prepare early
- Usage dashboard (requests, visits, submissions, API calls, downstream use).
- Community letters showing external reliance.
- Clear data provenance and quality-control workflow documentation.
- A practical interoperability map (which standards used, and how your data or API connects outward).
Budget strategy
The page does not publish a fixed top-line budget, but it does specify annual direct-cost limits:
- No more than $1.75M direct costs per year.
- Typically in the range of $500K to $1.75M per year.
Use this as both a ceiling and a planning constraint. Proposals with vague spending plans tend to be viewed as weak on stewardship.
Common mistakes to avoid
- Missing registrations before starting the final assembly.
- Submitting a component-heavy application with inconsistent terminology and duplicated narratives.
- Ignoring NIH’s component instructions (role fields, narrative scope, attachment limits).
- Underestimating local/system timing and attempting to “last-minute submit” with known error-correction risk.
- Overpromising novel research outcomes that read like primary R01 work rather than resource infrastructure.
Timing, milestones, and post-award implications
The submission timeline links three review stages in the standard NIH chain (peer review, advisory review, and earliest start window). The NOFO lists cycles for due dates and corresponding review/award windows, so applicants should be realistic about expectation windows and not assume immediate funding.
After award, recipients are expected to manage reporting through standard NIH systems and timelines, including annual progress and financial reporting under NIH policy. Data management and sharing obligations apply where appropriate under NIH policy.
This is a program that rewards execution discipline. Even before award, applicant institutions should have governance and operational plans for multi-year continuity, user support staffing, and policy-compliant data release.
Eligibility checklist
Use this checklist to quickly assess viability:
- Is your team U.S.-based and on a U.S.-eligible entity type?
- Is your work primarily resource development/maintenance, not a new clinical intervention?
- Is clinical-trial activity excluded?
- Are all required systems registrations active before submission?
- Can you demonstrate existing community adoption and data standards usage?
- Is the application organized with clear Overall, Core, and component logic?
- Is your budget within the direct-cost range and aligned with realistic staffing and computing needs?
- Have you planned an early-submission timeline (not exactly at 5:00 PM local on deadline day)?
Practical FAQ
Is this still “open”?
As of the current metadata date, the opportunity is active through September 26, 2027, with periodic due dates including 2026/2027 cycle deadlines.
Can for-profit organizations apply?
Yes, for-profit organizations and small businesses are listed in the eligible organizations, as long as other NIH policy requirements are met.
Can foreign collaborators participate?
Non-domestic non-U.S. components are not eligible applicants. Collaborative science is possible but principal applicant status and award accountability must remain within eligible structures.
Is this a clinical funding opportunity?
No. The NOFO explicitly says clinical trials are not allowed.
Can we submit both a new application and a renewal?
Yes. The NOFO allows new, renewal, resubmission, and revision where appropriate.
What is the largest advantage of a strong application?
Evidence of sustained, external utility and concrete plans for FAIR-aligned, interoperable dissemination usually dominate purely technical merit.
Official contacts and where to go next
For application-system issues, NIH points to the eRA Service Desk and grants operations channels. For research content questions, the NICHD contacts listed in the NOFO include both scientific and review-side contacts.
Useful official links:
Before pressing submit, confirm the following with your office team:
- Registration validity dates and PI credentials.
- Final component mapping and budget tables.
- Human/animal sections are accurate even if no trials are proposed.
- Required uploads and appendix constraints are respected.
This NOFO is best treated as a strategic infrastructure grant. If your resource already exists and you can prove impact, this is the right lane. If your team is just ideating a new app, this is usually the wrong lane and less competitive than the mechanism that fits early-stage discovery.
